Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 41-50 of 77

Page
per page
  1. PF-3758309
    A3716 PF-3758309
     1 Citation
    Target: PAK
    Summary: PAK4 inhibitor
      ≥24.53 mg/mL
  2. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  3. Poloxin
    A3732 Poloxin
    Target: PLK
    Summary: PLK1 inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  4. Pyridostatin
    A3742 Pyridostatin
     2 Citation
    Target: G-quadruplexes
    Summary: Drug used for promoting growth arrest
      ≥20.85 mg/mL
  5. Reversine
    A3760 Reversine
    Target: Aurora Kinases
    Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  6. RI-1
    A3764 RI-1
    Target: RAD51
    Summary: RAD51 inhibitor,cell-permeable
      insoluble in H2O; ≥18.1 mg/mL
  7. RKI-1447
    A3771 RKI-1447
    Target: ROCK
    Summary: Potent ROCK1/ROCK2 inhibitor
      insoluble in H2O; ≥16.3 mg/mL
  8. FRAX597
    B1162 FRAX597
     1 Citation
    Target: PAK
    Summary: PAK inhibitor,potent and ATP-competitive
      ≥27.9 mg/mL
  9. Dolastatin 10
    B1035 Dolastatin 10
    Target: Microtubules/Tubulins
    Summary: Antitumor agent
      ≥78.5 mg/mL
  10. IPA-3
    B2169 IPA-3
     1 Citation
    Target: PAK
    Summary: Non-ATP competitive Pak1 inhibitor
      insoluble in H2O; ≥16.1 mg/mL

Items 41-50 of 77

Page
per page